ENO2 and breast cancer: In Fig. 6a, the proliferation of breast cancer cells, except for SK-BR-3 cells, was increased by the treatment of compressed CAF-derived CM, which was significantly decreased by c-Jun inhibition or the knockdown of ENO2, HK2, or PFKFB3 genes in the compressed CAF cells.